Volumetric assessment in malignant pleural mesothelioma

被引：16
|
作者：
Murphy, David J.
Gill, Ritu R.
机构：
[1] Brigham & Womens Hosp, Dept Radiol, Div Thorac Imaging, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA USA
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2017年 / 5卷 / 11期
关键词：
Mesothelioma; CT; volume; volumetric CT; malignant pleural mesothelioma (MPM); POSITRON-EMISSION-TOMOGRAPHY; COMPUTED-TOMOGRAPHY; PROGNOSTIC-FACTORS; THERAPY RESPONSE; MODIFIED RECIST; TUMOR RESPONSE; LUNG-CANCER; FDG-PET/CT; SURVIVAL; CT;
D O I：
10.21037/atm.2017.05.23
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Malignant pleural mesothelioma (MPM) is a highly malignant pleural neoplasm with a dismal prognosis. Multimodality approach including surgery and chemotherapy are utilized to treat patients with resectable disease. Clinical staging allows for selection of patients for treatment strategies, but has not been found to be prognostic and is plagued by high interobserver variability. Tumor volume measurement on cross-sectional imaging has emerged as a potential quantitative tool with prognostic significance. This review focuses on volumetric assessment from cross-sectional imaging (CT, MRI, F-18-FDG PET/CT) and the potential prognostic benefit and applications.
引用
收藏
页数：7
相关论文
共 50 条
  • [21] Malignant pleural mesothelioma
    Boutin, C
    Schlesser, M
    Frenay, C
    Astoul, P
    EUROPEAN RESPIRATORY JOURNAL, 1998, 12 (04) : 972 - 981
  • [22] Malignant Pleural Mesothelioma
    Ettinger, David S.
    Akerley, Wallace
    Borghaei, Hossein
    Chang, Andrew
    Cheney, Richard T.
    Chirieac, Lucian R.
    D'Amico, Thomas A.
    Demmy, Todd L.
    Ganti, Apar Kishor P.
    Govindan, Ramaswamy
    Grannis, Frederic W., Jr.
    Horn, Leora
    Jahan, Thierry M.
    Jahanzeb, Mohammad
    Kessinger, Anne
    Komaki, Ritsuko
    Kong, Feng-Ming
    Kris, Mark G.
    Krug, Lee M.
    Lennes, Inga T.
    Loo, Billy W., Jr.
    Martins, Renato
    O'Malley, Janis
    Osarogiagbon, Raymond U.
    Otterson, Gregory A.
    Patel, Jyoti D.
    Pinder-Schenck, Mary
    Pisters, Katherine M.
    Reckamp, Karen
    Riely, Gregory J.
    Rohren, Eric
    Swanson, Scott J.
    Wood, Douglas E.
    Yang, Stephen C.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (01): : 26 - 41
  • [23] Malignant pleural mesothelioma
    Ceresoli, GL
    Betta, GP
    Castagneto, B
    Facciolo, F
    Arcangeli, G
    Zucali, PA
    Libener, R
    De Giovanni, D
    Melis, E
    Mirri, MA
    ANNALS OF ONCOLOGY, 2006, 17 : 13 - 16
  • [24] Malignant pleural mesothelioma
    Hoogsteden, HC
    Langerak, AW
    vanderKwast, TH
    Versnel, MA
    vanGelder, T
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1997, 25 (02) : 97 - 126
  • [25] Malignant pleural mesothelioma
    Hesdorffer, M. E.
    Leinwand, J.
    Taub, R. N.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2007, 37 (03): : 232 - 237
  • [26] Quantitative Assessment Using MR in Malignant Pleural Mesothelioma
    Gill, R.
    Bueno, R.
    Mazzola, E.
    Richard, W. G.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S115 - S115
  • [27] Malignant pleural mesothelioma
    Jacoulet, P
    Biron, E
    REVUE DES MALADIES RESPIRATOIRES, 2004, 21 (01) : 180 - 181
  • [28] MALIGNANT PLEURAL MESOTHELIOMA
    Honeyball, Florian
    Boyer, Michael
    van Zandwijk, Nico
    Kao, Steven C.
    CANCER FORUM, 2013, 37 (02) : 178 - 182
  • [29] Malignant pleural mesothelioma
    Walter Klepetko
    Wiener klinische Wochenschrift, 2016, 128 : 609 - 610
  • [30] Malignant Pleural Mesothelioma
    Edith Serna-Camacho, Monica
    Alfonso Cortes-Cardenas, Seir
    GACETA MEXICANA DE ONCOLOGIA, 2012, 11 (01): : 29 - 34
12345